Prevalence and management of castration-resistant prostate cancer of unknown metastatic status in the real-world setting: The AfroDiTA study
A substantial proportion of PC patients on ADT in the real-world setting are not appropriately followed up. Identification of CRPC-MX patients raised awareness among physicians and improved their adherence to guidelines, resulting in improved care for these patients.
Authors
- Alba Quesada-García
- J.L. Álvarez-Ossorio
- Ángela García García-Porrero
- M. Rodrigo-Aliaga (ORCID: https://orcid.org/0000-0003-3757-4027)
- A. Rodríguez Alonso (ORCID: https://orcid.org/0000-0001-7578-9753)
- A. Rodrı́guez-Antolı́n (ORCID: https://orcid.org/0000-0002-7841-708X)
- Jacobo Muñoz del Toro
Institutions
- Janssen (Belgium) (BE)
- Research Institute Hospital 12 de Octubre (ES)
- Unidades Centrales Científico-Técnicas (ES)
- Hospital General Universitari de Castelló (ES)
- Hospital Universitario Puerta del Mar (ES)
Publication Details
- Journal
- Urologic Oncology Seminars and Original Investigations
- Published
- 2024-09-21
- DOI
- https://doi.org/10.1016/j.urolonc.2024.09.003
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42